These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22759323)

  • 21. Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.
    Yee YK; Cheung TK; Chu KM; Chan CK; Fung J; Chan P; But D; Hung I; Chan AO; Yuen MF; Hsu A; Wong BC
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1063-7. PubMed ID: 17877513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Fakheri H; Bari Z; Sardarian H
    Helicobacter; 2012 Aug; 17(4):264-8. PubMed ID: 22759325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
    Koizumi W; Tanabe S; Nakatani K; Ishido K; Nishimura K; Azuma M; Ae T; Sasaki T; Higuchi K; Katada C; Nakayama N; Saigenji K
    J Clin Pharm Ther; 2010 Jun; 35(3):303-7. PubMed ID: 20831531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey.
    Aydin A; Oruc N; Turan I; Ozutemiz O; Tuncyurek M; Musoglu A
    Helicobacter; 2009 Dec; 14(6):520-4. PubMed ID: 19889069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance.
    Perna F; Zullo A; Ricci C; Hassan C; Morini S; Vaira D
    Dig Liver Dis; 2007 Nov; 39(11):1001-5. PubMed ID: 17889627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
    Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
    Valooran GJ; Kate V; Jagdish S; Basu D
    Scand J Gastroenterol; 2011 Sep; 46(9):1045-50. PubMed ID: 21627398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
    Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Gisbert JL; Marcos S; Pajares JM
    Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication.
    Ozdil K; Calhan T; Sahin A; Senates E; Kahraman R; Yüzbasioglu B; Demirdag H; Demirsoy H; Sökmen MH
    Hepatogastroenterology; 2011; 58(109):1148-52. PubMed ID: 21937367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication].
    Kang MS; Park DI; Yun JW; Oh SY; Yoo TW; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2006 Jan; 47(1):30-6. PubMed ID: 16434866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
    Kirstein FW; Epple HJ; Bojarski C; Victor L; Fromm M; Riecken EO; Schulzke JD
    Z Gastroenterol; 1998 Sep; 36(9):803-9. PubMed ID: 9795409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.